Clinical Trials Browser

Phase 1/2 × lutetium Lu 177 dotatate × Gastrointestinal × Clear all

NCT04614766 2024-04-29

SPORE-3

Phase 1/2 Withdrawn

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors